A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2017
Price : $35 *
At a glance
- Drugs Isometheptene (Primary)
- Indications Tension type headache
- Focus Proof of concept; Therapeutic Use
- Sponsors Tonix Pharmaceuticals Inc
- 26 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.